4SC AG Акции в обращении
Что обозначает Акции в обращении в 4SC AG?
Акции в обращении 4SC AG является 50.570M
Какое определение для Акции в обращении?
Акции в обращении - это все акции корпорации или финансового актива, которые были разрешены, выпущены и приобретены инвесторами и находятся в их собственности.
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
Акции в обращении компаний в Health Care сектор на XETRA по сравнению с 4SC AG
Что делает 4SC AG?
4SC AG, a clinical-stage biopharmaceutical company, engages in developing small-molecule drugs that target key indications in cancer with high unmet medical needs. The company's products in clinical development stage include Resminostat, an orally administered histone deacetylase inhibitor that is in Phase II clinical trial for the treatment of cutaneous T-cell lymphoma; and Domatinostat, an orally administered small molecule, which is in Phase Ib/II clinical trial for the treatment of melanoma and Phase II clinical trial for the treatment of gastrointestinal tumor. 4SC AG also out-licenses its products to pharma and biotech companies for the treatment of cancer. The company has a collaboration agreement with the Netherlands Cancer Institute to evaluate Domatinostat in the neoadjuvant setting in melanoma. 4SC AG was founded in 1997 and is headquartered in Planegg, Germany.
Компании с акции в обращении похож на 4SC AG
- Renewable Inc имеет Акции в обращении из 50.507M
- Gespeg Resources имеет Акции в обращении из 50.509M
- Cosmo Metals имеет Акции в обращении из 50.510M
- Cooper Tire & Rubber Co имеет Акции в обращении из 50.524M
- KFG Resources имеет Акции в обращении из 50.540M
- Cohen & Steers имеет Акции в обращении из 50.551M
- 4SC AG имеет Акции в обращении из 50.570M
- Tata Investment имеет Акции в обращении из 50.595M
- Tata Investment имеет Акции в обращении из 50.595M
- abrdn Healthcare Investors имеет Акции в обращении из 50.625M
- HeadHunter PLC имеет Акции в обращении из 50.636M
- Onxeo SA имеет Акции в обращении из 50.647M
- Forestar Inc имеет Акции в обращении из 50.654M